Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children

Background: In 2010, Greenland introduced the 13-valent pneumococcal conjugate vaccine (Prevnar 13®– PCV-13) in the childhood immunisation program. The authors aimed to evaluate the impact of PCV-13 on nasopharyngeal carriage of bacteria frequently associated with respiratory infections in children....

Full description

Bibliographic Details
Main Authors: Johan Emdal Navne, Anders Koch, Hans-Christian Slotved, Mikael Andersson, Mads Melbye, Karin Ladefoged, Malene Børresen
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:International Journal of Circumpolar Health
Subjects:
PCV-13
carriage
Inuit
respiratory infections
pneumococcus
Online Access:http://dx.doi.org/10.1080/22423982.2017.1309504

Similar Items

Similar Items